The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2016

Filed:

Sep. 06, 2012
Applicant:

Richard C. K. Yen, Yorba Linda, CA (US);

Inventor:

Richard C. K. Yen, Yorba Linda, CA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61P 7/02 (2006.01); A61K 38/38 (2006.01); A61K 9/00 (2006.01); A61K 38/36 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 9/5052 (2013.01); A61K 9/5169 (2013.01); A61K 38/363 (2013.01); A61K 9/10 (2013.01);
Abstract

A submicron protein sphere and method to intravenously treat a patient requiring blood component transfusion. The submicron protein spheres have a size ranging from 1.0 micron to less than 0.1 micron and a molecular weight ranging from 780 billion Daltons to less than 0.8 billion Daltons. The protein spheres have no biologically active molecules added or bound to the protein spheres prior to administering to the patient. The protein used to construct the spheres can be human serum albumin from natural sources or recombinant DNA-derived serum albumin, or other proteins such as gelatin or synthetic polypeptides. However, the protein spheres can bind the various clotting factors including fibrinogen after the spheres have entered the blood stream, binding the necessary additional biologically active molecules supplied in vivo from the patient's own blood, and possibly in vitro.


Find Patent Forward Citations

Loading…